Healios K.K.
Healios K.K. (HLOSF) Stock Competitors & Peer Comparison
See (HLOSF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HLOSF | $2.10 | +0.00% | 243M | -12.35 | -$0.17 | N/A |
| NONOF | $38.26 | +0.00% | 168.6B | 10.37 | $3.66 | +4.56% |
| CSLLY | $50.95 | +0.00% | 100.3B | 16.82 | $3.08 | +2.63% |
| UCBJY | $159.87 | +0.00% | 60.6B | 39.44 | $4.04 | +0.50% |
| UCBJF | $307.21 | -6.41% | 58.4B | 38.02 | $8.08 | +0.52% |
| ARGNF | $814.94 | +0.00% | 50.4B | 34.84 | $23.39 | N/A |
| CMXHF | $107.40 | +0.00% | 48B | 16.04 | $6.17 | +2.95% |
| WXXWY | $10.51 | +0.48% | 21.7B | 38.04 | $0.28 | N/A |
| WXIBF | $5.18 | +0.10% | 21.3B | 36.86 | $0.14 | N/A |
| IVBXF | $11.28 | -1.05% | 19.4B | 112.80 | $0.10 | N/A |
Stock Comparison
HLOSF vs NONOF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, NONOF has a market cap of 168.6B. Regarding current trading prices, HLOSF is priced at $2.10, while NONOF trades at $38.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas NONOF's P/E ratio is 10.37. In terms of profitability, HLOSF's ROE is -0.80%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, HLOSF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check NONOF's competition here
HLOSF vs CSLLY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CSLLY has a market cap of 100.3B. Regarding current trading prices, HLOSF is priced at $2.10, while CSLLY trades at $50.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CSLLY's P/E ratio is 16.82. In terms of profitability, HLOSF's ROE is -0.80%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, HLOSF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check CSLLY's competition here
HLOSF vs UCBJY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, UCBJY has a market cap of 60.6B. Regarding current trading prices, HLOSF is priced at $2.10, while UCBJY trades at $159.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas UCBJY's P/E ratio is 39.44. In terms of profitability, HLOSF's ROE is -0.80%, compared to UCBJY's ROE of +0.14%. Regarding short-term risk, HLOSF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check UCBJY's competition here
HLOSF vs UCBJF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, UCBJF has a market cap of 58.4B. Regarding current trading prices, HLOSF is priced at $2.10, while UCBJF trades at $307.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas UCBJF's P/E ratio is 38.02. In terms of profitability, HLOSF's ROE is -0.80%, compared to UCBJF's ROE of +0.14%. Regarding short-term risk, HLOSF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check UCBJF's competition here
HLOSF vs ARGNF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ARGNF has a market cap of 50.4B. Regarding current trading prices, HLOSF is priced at $2.10, while ARGNF trades at $814.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ARGNF's P/E ratio is 34.84. In terms of profitability, HLOSF's ROE is -0.80%, compared to ARGNF's ROE of +0.22%. Regarding short-term risk, HLOSF and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
HLOSF vs CMXHF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CMXHF has a market cap of 48B. Regarding current trading prices, HLOSF is priced at $2.10, while CMXHF trades at $107.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CMXHF's P/E ratio is 16.04. In terms of profitability, HLOSF's ROE is -0.80%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, HLOSF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check CMXHF's competition here
HLOSF vs WXXWY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, WXXWY has a market cap of 21.7B. Regarding current trading prices, HLOSF is priced at $2.10, while WXXWY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas WXXWY's P/E ratio is 38.04. In terms of profitability, HLOSF's ROE is -0.80%, compared to WXXWY's ROE of +0.10%. Regarding short-term risk, HLOSF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check WXXWY's competition here
HLOSF vs WXIBF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, WXIBF has a market cap of 21.3B. Regarding current trading prices, HLOSF is priced at $2.10, while WXIBF trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas WXIBF's P/E ratio is 36.86. In terms of profitability, HLOSF's ROE is -0.80%, compared to WXIBF's ROE of +0.10%. Regarding short-term risk, HLOSF and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
HLOSF vs IVBXF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, IVBXF has a market cap of 19.4B. Regarding current trading prices, HLOSF is priced at $2.10, while IVBXF trades at $11.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas IVBXF's P/E ratio is 112.80. In terms of profitability, HLOSF's ROE is -0.80%, compared to IVBXF's ROE of +0.08%. Regarding short-term risk, HLOSF and IVBXF have similar daily volatility (0.00).Check IVBXF's competition here
HLOSF vs GNMSF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, GNMSF has a market cap of 17.9B. Regarding current trading prices, HLOSF is priced at $2.10, while GNMSF trades at $290.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas GNMSF's P/E ratio is 12.70. In terms of profitability, HLOSF's ROE is -0.80%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, HLOSF and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here
HLOSF vs SBMFF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SBMFF has a market cap of 15B. Regarding current trading prices, HLOSF is priced at $2.10, while SBMFF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SBMFF's P/E ratio is 28.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, HLOSF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
HLOSF vs SBHMY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, HLOSF is priced at $2.10, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SBHMY's P/E ratio is 25.22. In terms of profitability, HLOSF's ROE is -0.80%, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, HLOSF and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here
HLOSF vs AAVXF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, AAVXF has a market cap of 9.9B. Regarding current trading prices, HLOSF is priced at $2.10, while AAVXF trades at $125.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas AAVXF's P/E ratio is -24.03. In terms of profitability, HLOSF's ROE is -0.80%, compared to AAVXF's ROE of +50.78%. Regarding short-term risk, HLOSF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
HLOSF vs BRRGF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, HLOSF is priced at $2.10, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, HLOSF's ROE is -0.80%, compared to BRRGF's ROE of -1.05%. Regarding short-term risk, HLOSF and BRRGF have similar daily volatility (0.00).Check BRRGF's competition here
HLOSF vs ODTC Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, HLOSF is priced at $2.10, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ODTC's P/E ratio is 1.07. In terms of profitability, HLOSF's ROE is -0.80%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, HLOSF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
HLOSF vs AKBLF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, AKBLF has a market cap of 7.3B. Regarding current trading prices, HLOSF is priced at $2.10, while AKBLF trades at $36.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas AKBLF's P/E ratio is 45.70. In terms of profitability, HLOSF's ROE is -0.80%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, HLOSF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
HLOSF vs TRSBF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, TRSBF has a market cap of 6.2B. Regarding current trading prices, HLOSF is priced at $2.10, while TRSBF trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas TRSBF's P/E ratio is 18.71. In terms of profitability, HLOSF's ROE is -0.80%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, HLOSF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
HLOSF vs REGMF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, REGMF has a market cap of 5.9B. Regarding current trading prices, HLOSF is priced at $2.10, while REGMF trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas REGMF's P/E ratio is -33.71. In terms of profitability, HLOSF's ROE is -0.80%, compared to REGMF's ROE of -0.45%. Regarding short-term risk, HLOSF and REGMF have similar daily volatility (0.00).Check REGMF's competition here
HLOSF vs ABCZF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, HLOSF is priced at $2.10, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, HLOSF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
HLOSF vs LABFF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, HLOSF is priced at $2.10, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas LABFF's P/E ratio is 28.95. In terms of profitability, HLOSF's ROE is -0.80%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, HLOSF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
HLOSF vs SHJBF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SHJBF has a market cap of 4.1B. Regarding current trading prices, HLOSF is priced at $2.10, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SHJBF's P/E ratio is -20.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to SHJBF's ROE of -0.16%. Regarding short-term risk, HLOSF and SHJBF have similar daily volatility (0.00).Check SHJBF's competition here
HLOSF vs ZLDPF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ZLDPF has a market cap of 4B. Regarding current trading prices, HLOSF is priced at $2.10, while ZLDPF trades at $56.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ZLDPF's P/E ratio is 3.96. In terms of profitability, HLOSF's ROE is -0.80%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, HLOSF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check ZLDPF's competition here
HLOSF vs GNNSF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, GNNSF has a market cap of 3.8B. Regarding current trading prices, HLOSF is priced at $2.10, while GNNSF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas GNNSF's P/E ratio is -43.75. In terms of profitability, HLOSF's ROE is -0.80%, compared to GNNSF's ROE of +0.71%. Regarding short-term risk, HLOSF and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
HLOSF vs CAMRF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CAMRF has a market cap of 3.5B. Regarding current trading prices, HLOSF is priced at $2.10, while CAMRF trades at $58.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CAMRF's P/E ratio is 42.96. In terms of profitability, HLOSF's ROE is -0.80%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, HLOSF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
HLOSF vs BRCTF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BRCTF has a market cap of 3.4B. Regarding current trading prices, HLOSF is priced at $2.10, while BRCTF trades at $38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BRCTF's P/E ratio is 30.40. In terms of profitability, HLOSF's ROE is -0.80%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, HLOSF and BRCTF have similar daily volatility (0.00).Check BRCTF's competition here
HLOSF vs ASPHF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, HLOSF is priced at $2.10, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to ASPHF's ROE of -1.40%. Regarding short-term risk, HLOSF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
HLOSF vs MPSYF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, HLOSF is priced at $2.10, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, HLOSF's ROE is -0.80%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, HLOSF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check MPSYF's competition here
HLOSF vs GENSF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, GENSF has a market cap of 2.5B. Regarding current trading prices, HLOSF is priced at $2.10, while GENSF trades at $37.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas GENSF's P/E ratio is 95.51. In terms of profitability, HLOSF's ROE is -0.80%, compared to GENSF's ROE of +0.04%. Regarding short-term risk, HLOSF and GENSF have similar daily volatility (0.00).Check GENSF's competition here
HLOSF vs BVNRY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BVNRY has a market cap of 2.4B. Regarding current trading prices, HLOSF is priced at $2.10, while BVNRY trades at $10.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BVNRY's P/E ratio is 6.35. In terms of profitability, HLOSF's ROE is -0.80%, compared to BVNRY's ROE of +0.20%. Regarding short-term risk, HLOSF and BVNRY have similar daily volatility (0.00).Check BVNRY's competition here
HLOSF vs BVNKF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, HLOSF is priced at $2.10, while BVNKF trades at $30.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BVNKF's P/E ratio is 6.24. In terms of profitability, HLOSF's ROE is -0.80%, compared to BVNKF's ROE of +0.20%. Regarding short-term risk, HLOSF and BVNKF have similar daily volatility (0.00).Check BVNKF's competition here
HLOSF vs INCPF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, HLOSF is priced at $2.10, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas INCPF's P/E ratio is -77.50. In terms of profitability, HLOSF's ROE is -0.80%, compared to INCPF's ROE of -0.03%. Regarding short-term risk, HLOSF and INCPF have similar daily volatility (0.00).Check INCPF's competition here
HLOSF vs TLPPF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, TLPPF has a market cap of 2.3B. Regarding current trading prices, HLOSF is priced at $2.10, while TLPPF trades at $6.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas TLPPF's P/E ratio is 340.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, HLOSF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check TLPPF's competition here
HLOSF vs GLPGF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, HLOSF is priced at $2.10, while GLPGF trades at $34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas GLPGF's P/E ratio is -4.24. In terms of profitability, HLOSF's ROE is -0.80%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, HLOSF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
HLOSF vs ASCLF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ASCLF has a market cap of 2.1B. Regarding current trading prices, HLOSF is priced at $2.10, while ASCLF trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ASCLF's P/E ratio is -53.87. In terms of profitability, HLOSF's ROE is -0.80%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, HLOSF and ASCLF have similar daily volatility (0.00).Check ASCLF's competition here
HLOSF vs MEOBF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, HLOSF is priced at $2.10, while MEOBF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas MEOBF's P/E ratio is -15.90. In terms of profitability, HLOSF's ROE is -0.80%, compared to MEOBF's ROE of -0.19%. Regarding short-term risk, HLOSF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check MEOBF's competition here
HLOSF vs ONTTF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ONTTF has a market cap of 1.8B. Regarding current trading prices, HLOSF is priced at $2.10, while ONTTF trades at $1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ONTTF's P/E ratio is -9.25. In terms of profitability, HLOSF's ROE is -0.80%, compared to ONTTF's ROE of -0.26%. Regarding short-term risk, HLOSF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check ONTTF's competition here
HLOSF vs BIESF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, HLOSF is priced at $2.10, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BIESF's P/E ratio is -44.44. In terms of profitability, HLOSF's ROE is -0.80%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, HLOSF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
HLOSF vs PHMMF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, PHMMF has a market cap of 1.5B. Regarding current trading prices, HLOSF is priced at $2.10, while PHMMF trades at $88.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas PHMMF's P/E ratio is 38.57. In terms of profitability, HLOSF's ROE is -0.80%, compared to PHMMF's ROE of +0.17%. Regarding short-term risk, HLOSF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
HLOSF vs HBMHF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, HLOSF is priced at $2.10, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, HLOSF's ROE is -0.80%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, HLOSF and HBMHF have similar daily volatility (0.00).Check HBMHF's competition here
HLOSF vs SNBIF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, HLOSF is priced at $2.10, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, HLOSF's ROE is -0.80%, compared to SNBIF's ROE of -2.53%. Regarding short-term risk, HLOSF and SNBIF have similar daily volatility (0.00).Check SNBIF's competition here
HLOSF vs IDRSF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, IDRSF has a market cap of 1.3B. Regarding current trading prices, HLOSF is priced at $2.10, while IDRSF trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas IDRSF's P/E ratio is -6.35. In terms of profitability, HLOSF's ROE is -0.80%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, HLOSF and IDRSF have similar daily volatility (0.00).Check IDRSF's competition here
HLOSF vs CSPHF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CSPHF has a market cap of 1.3B. Regarding current trading prices, HLOSF is priced at $2.10, while CSPHF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CSPHF's P/E ratio is -21.52. In terms of profitability, HLOSF's ROE is -0.80%, compared to CSPHF's ROE of -0.71%. Regarding short-term risk, HLOSF and CSPHF have similar daily volatility (0.00).Check CSPHF's competition here
HLOSF vs CSBTF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, HLOSF is priced at $2.10, while CSBTF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CSBTF's P/E ratio is -160.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to CSBTF's ROE of -0.08%. Regarding short-term risk, HLOSF and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
HLOSF vs MDCLF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, HLOSF is priced at $2.10, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, HLOSF's ROE is -0.80%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, HLOSF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
HLOSF vs PPTDF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, PPTDF has a market cap of 1.1B. Regarding current trading prices, HLOSF is priced at $2.10, while PPTDF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas PPTDF's P/E ratio is -46.58. In terms of profitability, HLOSF's ROE is -0.80%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, HLOSF and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
HLOSF vs PHGUF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, HLOSF is priced at $2.10, while PHGUF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas PHGUF's P/E ratio is -160.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to PHGUF's ROE of +0.00%. Regarding short-term risk, HLOSF and PHGUF have similar daily volatility (0.00).Check PHGUF's competition here
HLOSF vs NURPF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, HLOSF is priced at $2.10, while NURPF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas NURPF's P/E ratio is 10.52. In terms of profitability, HLOSF's ROE is -0.80%, compared to NURPF's ROE of +0.43%. Regarding short-term risk, HLOSF and NURPF have similar daily volatility (0.00).Check NURPF's competition here
HLOSF vs INRLF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, INRLF has a market cap of 1B. Regarding current trading prices, HLOSF is priced at $2.10, while INRLF trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas INRLF's P/E ratio is -7.66. In terms of profitability, HLOSF's ROE is -0.80%, compared to INRLF's ROE of -0.59%. Regarding short-term risk, HLOSF and INRLF have similar daily volatility (0.00).Check INRLF's competition here
HLOSF vs BTTAY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, HLOSF is priced at $2.10, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, HLOSF's ROE is -0.80%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, HLOSF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check BTTAY's competition here
HLOSF vs TKBIF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, HLOSF is priced at $2.10, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas TKBIF's P/E ratio is -21.47. In terms of profitability, HLOSF's ROE is -0.80%, compared to TKBIF's ROE of N/A. Regarding short-term risk, HLOSF and TKBIF have similar daily volatility (0.00).Check TKBIF's competition here
HLOSF vs BPMUF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, HLOSF is priced at $2.10, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, HLOSF's ROE is -0.80%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, HLOSF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
HLOSF vs VBIZF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, HLOSF is priced at $2.10, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, HLOSF's ROE is -0.80%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, HLOSF and VBIZF have similar daily volatility (0.00).Check VBIZF's competition here
HLOSF vs IVEVF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, IVEVF has a market cap of 617.4M. Regarding current trading prices, HLOSF is priced at $2.10, while IVEVF trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas IVEVF's P/E ratio is -1.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, HLOSF and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here
HLOSF vs CKDXF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, HLOSF is priced at $2.10, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, HLOSF's ROE is -0.80%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, HLOSF and CKDXF have similar daily volatility (0.00).Check CKDXF's competition here
HLOSF vs GNFTF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, GNFTF has a market cap of 492.4M. Regarding current trading prices, HLOSF is priced at $2.10, while GNFTF trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas GNFTF's P/E ratio is -10.62. In terms of profitability, HLOSF's ROE is -0.80%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, HLOSF and GNFTF have similar daily volatility (0.00).Check GNFTF's competition here
HLOSF vs SOLTF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SOLTF has a market cap of 492.3M. Regarding current trading prices, HLOSF is priced at $2.10, while SOLTF trades at $5.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SOLTF's P/E ratio is -6.04. In terms of profitability, HLOSF's ROE is -0.80%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, HLOSF and SOLTF have similar daily volatility (0.00).Check SOLTF's competition here
HLOSF vs GNFTY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, GNFTY has a market cap of 475.3M. Regarding current trading prices, HLOSF is priced at $2.10, while GNFTY trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas GNFTY's P/E ratio is -10.22. In terms of profitability, HLOSF's ROE is -0.80%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, HLOSF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check GNFTY's competition here
HLOSF vs RAONF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, HLOSF is priced at $2.10, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas RAONF's P/E ratio is -43.33. In terms of profitability, HLOSF's ROE is -0.80%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, HLOSF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check RAONF's competition here
HLOSF vs TBGNF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, HLOSF is priced at $2.10, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, HLOSF's ROE is -0.80%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, HLOSF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
HLOSF vs CLVLF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, HLOSF is priced at $2.10, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, HLOSF's ROE is -0.80%, compared to CLVLF's ROE of +0.16%. Regarding short-term risk, HLOSF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
HLOSF vs CLVLY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CLVLY has a market cap of 413.7M. Regarding current trading prices, HLOSF is priced at $2.10, while CLVLY trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CLVLY's P/E ratio is 16.16. In terms of profitability, HLOSF's ROE is -0.80%, compared to CLVLY's ROE of +0.16%. Regarding short-term risk, HLOSF and CLVLY have similar daily volatility (0.00).Check CLVLY's competition here
HLOSF vs PTCHF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, PTCHF has a market cap of 410.4M. Regarding current trading prices, HLOSF is priced at $2.10, while PTCHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas PTCHF's P/E ratio is 9.99. In terms of profitability, HLOSF's ROE is -0.80%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, HLOSF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
HLOSF vs AVCTF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, AVCTF has a market cap of 372.9M. Regarding current trading prices, HLOSF is priced at $2.10, while AVCTF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas AVCTF's P/E ratio is -5.68. In terms of profitability, HLOSF's ROE is -0.80%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, HLOSF and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
HLOSF vs PRRUF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, PRRUF has a market cap of 368M. Regarding current trading prices, HLOSF is priced at $2.10, while PRRUF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas PRRUF's P/E ratio is -8.33. In terms of profitability, HLOSF's ROE is -0.80%, compared to PRRUF's ROE of -0.27%. Regarding short-term risk, HLOSF and PRRUF have similar daily volatility (0.00).Check PRRUF's competition here
HLOSF vs NWBO Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, NWBO has a market cap of 359.1M. Regarding current trading prices, HLOSF is priced at $2.10, while NWBO trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas NWBO's P/E ratio is -3.88. In terms of profitability, HLOSF's ROE is -0.80%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, HLOSF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check NWBO's competition here
HLOSF vs CYDY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CYDY has a market cap of 330.3M. Regarding current trading prices, HLOSF is priced at $2.10, while CYDY trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CYDY's P/E ratio is -8.67. In terms of profitability, HLOSF's ROE is -0.80%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, HLOSF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check CYDY's competition here
HLOSF vs NGENF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, NGENF has a market cap of 328.7M. Regarding current trading prices, HLOSF is priced at $2.10, while NGENF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas NGENF's P/E ratio is -15.96. In terms of profitability, HLOSF's ROE is -0.80%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, HLOSF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check NGENF's competition here
HLOSF vs CMVLF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CMVLF has a market cap of 325.5M. Regarding current trading prices, HLOSF is priced at $2.10, while CMVLF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CMVLF's P/E ratio is -13.64. In terms of profitability, HLOSF's ROE is -0.80%, compared to CMVLF's ROE of -0.32%. Regarding short-term risk, HLOSF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
HLOSF vs SPHDF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SPHDF has a market cap of 294.9M. Regarding current trading prices, HLOSF is priced at $2.10, while SPHDF trades at $21.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SPHDF's P/E ratio is -3.03. In terms of profitability, HLOSF's ROE is -0.80%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, HLOSF and SPHDF have similar daily volatility (0.00).Check SPHDF's competition here
HLOSF vs PBBIF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, HLOSF is priced at $2.10, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, HLOSF's ROE is -0.80%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, HLOSF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
HLOSF vs FGHQF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, FGHQF has a market cap of 283.9M. Regarding current trading prices, HLOSF is priced at $2.10, while FGHQF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas FGHQF's P/E ratio is 14.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, HLOSF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
HLOSF vs ORYZF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ORYZF has a market cap of 283.9M. Regarding current trading prices, HLOSF is priced at $2.10, while ORYZF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ORYZF's P/E ratio is -90.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, HLOSF and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here
HLOSF vs ORPOF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, HLOSF is priced at $2.10, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, HLOSF's ROE is -0.80%, compared to ORPOF's ROE of N/A. Regarding short-term risk, HLOSF and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
HLOSF vs HNSBF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, HLOSF is priced at $2.10, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas HNSBF's P/E ratio is -4.03. In terms of profitability, HLOSF's ROE is -0.80%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, HLOSF and HNSBF have similar daily volatility (0.00).Check HNSBF's competition here
HLOSF vs NWPHF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, NWPHF has a market cap of 239.5M. Regarding current trading prices, HLOSF is priced at $2.10, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas NWPHF's P/E ratio is N/A. In terms of profitability, HLOSF's ROE is -0.80%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, HLOSF and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
HLOSF vs SLNCF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, HLOSF is priced at $2.10, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SLNCF's P/E ratio is -3.56. In terms of profitability, HLOSF's ROE is -0.80%, compared to SLNCF's ROE of -1.47%. Regarding short-term risk, HLOSF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
HLOSF vs CAIHF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, HLOSF is priced at $2.10, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, HLOSF's ROE is -0.80%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, HLOSF and CAIHF have similar daily volatility (0.00).Check CAIHF's competition here
HLOSF vs BOVNF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, HLOSF is priced at $2.10, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to BOVNF's ROE of -0.41%. Regarding short-term risk, HLOSF and BOVNF have similar daily volatility (0.00).Check BOVNF's competition here
HLOSF vs FPHAF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, HLOSF is priced at $2.10, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, HLOSF's ROE is -0.80%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, HLOSF and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
HLOSF vs SCNLF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SCNLF has a market cap of 189.4M. Regarding current trading prices, HLOSF is priced at $2.10, while SCNLF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SCNLF's P/E ratio is -18.25. In terms of profitability, HLOSF's ROE is -0.80%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, HLOSF and SCNLF have similar daily volatility (0.00).Check SCNLF's competition here
HLOSF vs IPHYF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, IPHYF has a market cap of 186.5M. Regarding current trading prices, HLOSF is priced at $2.10, while IPHYF trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas IPHYF's P/E ratio is -3.06. In terms of profitability, HLOSF's ROE is -0.80%, compared to IPHYF's ROE of -6.59%. Regarding short-term risk, HLOSF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
HLOSF vs KNTPF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, KNTPF has a market cap of 184M. Regarding current trading prices, HLOSF is priced at $2.10, while KNTPF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas KNTPF's P/E ratio is -6.54. In terms of profitability, HLOSF's ROE is -0.80%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, HLOSF and KNTPF have similar daily volatility (0.00).Check KNTPF's competition here
HLOSF vs MSCLF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, MSCLF has a market cap of 174.1M. Regarding current trading prices, HLOSF is priced at $2.10, while MSCLF trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas MSCLF's P/E ratio is 4.38. In terms of profitability, HLOSF's ROE is -0.80%, compared to MSCLF's ROE of -0.52%. Regarding short-term risk, HLOSF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check MSCLF's competition here
HLOSF vs ADOCY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, HLOSF is priced at $2.10, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, HLOSF's ROE is -0.80%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, HLOSF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
HLOSF vs BBIXF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BBIXF has a market cap of 157.7M. Regarding current trading prices, HLOSF is priced at $2.10, while BBIXF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BBIXF's P/E ratio is -13.50. In terms of profitability, HLOSF's ROE is -0.80%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, HLOSF and BBIXF have similar daily volatility (0.00).Check BBIXF's competition here
HLOSF vs SPHRY Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SPHRY has a market cap of 140.7M. Regarding current trading prices, HLOSF is priced at $2.10, while SPHRY trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SPHRY's P/E ratio is -55.83. In terms of profitability, HLOSF's ROE is -0.80%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, HLOSF and SPHRY have similar daily volatility (0.00).Check SPHRY's competition here
HLOSF vs AMGXF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, HLOSF is priced at $2.10, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, HLOSF's ROE is -0.80%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, HLOSF and AMGXF have similar daily volatility (0.00).Check AMGXF's competition here
HLOSF vs BRIBF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, HLOSF is priced at $2.10, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas BRIBF's P/E ratio is -2.35. In terms of profitability, HLOSF's ROE is -0.80%, compared to BRIBF's ROE of -0.07%. Regarding short-term risk, HLOSF and BRIBF have similar daily volatility (0.00).Check BRIBF's competition here
HLOSF vs SPHRF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, SPHRF has a market cap of 134.4M. Regarding current trading prices, HLOSF is priced at $2.10, while SPHRF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas SPHRF's P/E ratio is -32.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, HLOSF and SPHRF have similar daily volatility (0.00).Check SPHRF's competition here
HLOSF vs HBPCF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, HLOSF is priced at $2.10, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, HLOSF's ROE is -0.80%, compared to HBPCF's ROE of -0.65%. Regarding short-term risk, HLOSF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
HLOSF vs TRGNF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, HLOSF is priced at $2.10, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, HLOSF's ROE is -0.80%, compared to TRGNF's ROE of -6.34%. Regarding short-term risk, HLOSF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check TRGNF's competition here
HLOSF vs MLLCF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, MLLCF has a market cap of 130.9M. Regarding current trading prices, HLOSF is priced at $2.10, while MLLCF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas MLLCF's P/E ratio is -1.67. In terms of profitability, HLOSF's ROE is -0.80%, compared to MLLCF's ROE of -0.51%. Regarding short-term risk, HLOSF and MLLCF have similar daily volatility (0.00).Check MLLCF's competition here
HLOSF vs NDTP Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, NDTP has a market cap of 129.6M. Regarding current trading prices, HLOSF is priced at $2.10, while NDTP trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas NDTP's P/E ratio is -2.53. In terms of profitability, HLOSF's ROE is -0.80%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, HLOSF is less volatile compared to NDTP. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check NDTP's competition here
HLOSF vs JWCTF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, JWCTF has a market cap of 127.5M. Regarding current trading prices, HLOSF is priced at $2.10, while JWCTF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, HLOSF's ROE is -0.80%, compared to JWCTF's ROE of -0.59%. Regarding short-term risk, HLOSF and JWCTF have similar daily volatility (0.00).Check JWCTF's competition here
HLOSF vs AAPGV Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, HLOSF is priced at $2.10, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas AAPGV's P/E ratio is N/A. In terms of profitability, HLOSF's ROE is -0.80%, compared to AAPGV's ROE of -2.49%. Regarding short-term risk, HLOSF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check AAPGV's competition here
HLOSF vs PSTTF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, HLOSF is priced at $2.10, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, HLOSF's ROE is -0.80%, compared to PSTTF's ROE of N/A. Regarding short-term risk, HLOSF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
HLOSF vs PRNAF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, PRNAF has a market cap of 109.8M. Regarding current trading prices, HLOSF is priced at $2.10, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas PRNAF's P/E ratio is -1.01. In terms of profitability, HLOSF's ROE is -0.80%, compared to PRNAF's ROE of -0.38%. Regarding short-term risk, HLOSF and PRNAF have similar daily volatility (0.00).Check PRNAF's competition here
HLOSF vs EPRXF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, HLOSF is priced at $2.10, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, HLOSF's ROE is -0.80%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, HLOSF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for HLOSF.Check EPRXF's competition here
HLOSF vs ATGGF Comparison February 2026
HLOSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLOSF stands at 243M. In comparison, ATGGF has a market cap of 107.7M. Regarding current trading prices, HLOSF is priced at $2.10, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLOSF currently has a P/E ratio of -12.35, whereas ATGGF's P/E ratio is N/A. In terms of profitability, HLOSF's ROE is -0.80%, compared to ATGGF's ROE of -0.70%. Regarding short-term risk, HLOSF and ATGGF have similar daily volatility (0.00).Check ATGGF's competition here